Topical antifungals accounted for the highest share of value sales of dermatologicals in 2019 and throughout the review period. Unlike other specific products within dermatologicals, which can only be found in chemists/pharmacies, topical antifungals can easily be found and purchased in drugstores/parapharmacies as well.
Antiparasitics/lice (head and body) treatments accounted for the second largest share of value sales in 2019 and it is also set to post a strong current value CAGR over the forecast period due to innovations and new product developments such as Laboratorio Roemmers’ launch of a new treatment targeting children in February, accompanied by strong promotion and communication strategies, while hair loss treatments is expected to thrive, driven by continuous innovations and future new releases.
Within a society as traditional as Uruguay is, it is not surprising that many people feel uncomfortable about asking for certain intimate products such as haemorrhoid treatments and vaginal antifungals. For this reason many Uruguayans have traditionally postponed or entirely foregone making such purchases at chemists/pharmacists in the hope that the problem will subside without having to visit a pharmacy or the doctor.
Laboratorio Roemmers maintained its leading position in dermatologicals in 2019 on the strength of its brands in several categories. Its vaginal antifungals brand Vitapel and topical antifungal brand Micolis rank second in their respective categories.
Topical antifungals is the largest category within dermatologicals, and the multinational Bayer SA Uruguay continued to dominate value sales in this category in 2019 with its general-purpose brand Canesten. One of the products the company recently discontinued was another topical antifungal, general-purpose Icaden, sales of which were only a fraction of those of Canesten.
Local company Urufarma performed very well in dermatologicals over the review period, with its dominant position of its famous Hipoglós brand within nappy/diaper rash treatments. Moreover, the company’s value share increased in 2019 for the fourth consecutive year.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Uruguay with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Medicated Skin Care industry in Uruguay, our research will save you time and money while empowering you to make informed, profitable decisions.
The Medicated Skin Care in Uruguay market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.